Mohamed, W A <br/><br/>
A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn.  [electronic resource] 

 -  Journal of perinatology : official journal of the California Perinatal Association  Aug 2012 
 - 608-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1476-5543 
<br/><br/><label>Standard No.: </label>10.1038/jp.2011.157  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antihypertensive Agents--adverse effects<br/>Bosentan<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Hypertension, Pulmonary--drug therapy<br/>Infant, Newborn<br/>Male<br/>Prospective Studies<br/>Sulfonamides--adverse effects<br/>Treatment Outcome